Hospital spending continues to outgrow GP investment In its healthcare expenditure analysis, the AIHW finds an ever-greater share going to hospitals as general practice spending flattens.
Pharma marketing linked to less appropriate prescribing: Cochrane Review No Australian studies were included in the research, but authors say its findings are relevant for GPs here.
Urgent call for prescribers to help amid opioid crisis Face-to-face workshops in Victoria will help GPs gain MATOD accreditation and build confidence in opioid dependence treatment.
Polypharmacy among almost two million Australians A new AIHW report reveals the number of people on multiple medications is expected to rise. How can GPs help mitigate the risks?
Telehealth firms accused of bypassing veterans’ regular GPs A ‘deeply concerning’ Four Corners investigation alleges providers are putting profit ahead of veteran wellbeing, and cutting out regular general practice.
RACGP calls for formal recognition of GPs’ role in NDIS assessments In a submission on proposed changes, it says fully delegating this task to assessors who do not know the patient would be ‘problematic’.
PIP QI data points to improvements in chronic disease care New AIHW figures reveal increases in HbA1c monitoring, CVD assessment and cervical screening, based on data from almost 5900 practices.
OpenAI apologises for Medicare breach As the company reveals more detail of its unauthorised access to Services Australia, a GP expert warns the incident is unlikely to be the last, and practices must act.
Concern over removal of another opioid use disorder treatment US-based pharmaceutical company Indivior has made a commercial decision to stop the supply of Subutex by the end of 2027.
GP poll a warning on ‘squeezed’ preventive care Of more than 2000 GPs surveyed in the UK, 75% found they did not have enough time to offer more holistic health guidance.